孕期及产后足部形态变化与患者疼痛和功能相关
本研究采用新型多平面数字相机系统纵向评估孕妇足部形态变化,发现从孕早期到孕晚期足宽、足背高度、足长及内侧足面积增加,且这些变化与PROMIS疼痛干扰和身体功能评分中具有临床意义的改变相关。结论提示足部形态变化可能成为管理孕期肌肉骨骼疼痛的干预靶点。
要点
- 从孕早期到孕晚期,足宽、足背高度、足长及内侧足面积均显著增加。
- 疼痛干扰临床重要增加者,孕晚期及产后右内侧足面积更大。
- 身体功能临床重要下降者,孕早期至孕晚期右内侧足面积增加更明显。
核心结论
- 孕期足部形态变化与患者报告的疼痛干扰和身体功能下降相关,主要与妊娠诱导的下肢水肿有关。
研究设计与样本
- 前瞻性纵向队列研究,纳入31名孕妇(平均年龄35±4岁,平均BMI 68.8±11.8 kg)和18名非妊娠对照(平均年龄28±4岁,平均BMI 62.7±6.4 kg),在孕早、中、晚期及产后9-15周进行足部形态评估和PROMIS评分。
主要发现
- 左足宽从孕早期9.14 cm增至孕晚期9.30 cm(中位差+0.21 cm,95%CI 0.06-0.25,p=0.02),左足背高度从6.22 cm增至6.33 cm(中位差+0.17 cm,95%CI 0.01-0.46,p=0.03),右足背高度从6.30 cm增至6.50 cm(中位差+0.23 cm,95%CI 0.13-0.38,p=0.008)。
- 左足长从24.37±1.24 cm增至24.66±1.12 cm(平均差+0.29 cm,95%CI 0.09-0.49,p=0.03),左内侧足面积从83.08±7.12 cm2增至87.30±7.15 cm2(平均差+4.22 cm2,95%CI 2.19-6.25,p=0.001),右内侧足面积从84.02±7.71 cm2增至88.10±8.53 cm2(平均差+4.08 cm2,95%CI 2.21-5.94,p<0.001)。
- 左足宽从孕早期9.14 cm增至产后9.42 cm(中位差+0.10 cm,95%CI 0.09-0.37,p=0.01)。
- 疼痛干扰临床重要增加者,孕晚期右内侧足面积11.37 cm2/鞋码(范围9.72-15.97)高于对照10.35 cm2/鞋码(范围8.76-11.54),中位差+1.02 cm2/鞋码(95%CI 0.42-1.73,p=0.005);产后为11.26 cm2/鞋码(范围9.88-15.47),中位差+0.91 cm2/鞋码(95%CI 0.04-2.57,p=0.01)。
- 疼痛干扰临床重要增加者右足长从孕早期至孕晚期增加0.49±0.59 cm,大于无疼痛干扰变化者的-0.14±0.49 cm(平均差0.63 cm,95%CI 0.21-1.06,p=0.005);身体功能临床重要下降者右内侧足面积增加6.62±4.94 cm2,大于无下降者的1.98±4.00 cm2(平均差4.64 cm2,95%CI 1.14-4.64,p=0.01)。
关键数值与推荐
- PROMIS疼痛干扰和身体功能评分均为标准化T分(范围20-80),疼痛干扰越高、身体功能越低表示结果越差。
- 足踝骨科中疼痛干扰和身体功能的的最小临床重要差异范围为5.5-9.8 T分,本研究采用>10(1个标准差)作为临床重要变化的保守阈值。
临床怎么用
- 孕期足部形态变化(尤其内侧足面积增加)与疼痛干扰和功能下降相关,可指导压缩袜、按摩或抬高足部等干预措施以减轻肌肉骨骼疼痛和残疾。
局限性
- 样本量较小(31名孕妇完成分析),可能限制统计效能和普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Foot pain and symptoms affect 42% of pregnant women and extend beyond gestation, but the associations between foot morphology and these symptoms are not well understood. We sought to identify changes in foot shape throughout pregnancy and postpartum, using a novel multiplane digital camera-based system and to determine whether these alterations are associated with clinically important changes in the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference and Physical Function scores. QUESTIONS/PURPOSES: (1) How does foot width, length, dorsum height, Arch Height Index, and medial foot area change throughout pregnancy and postpartum? (2) Are there relationships between foot shape and changes in foot shape over time with clinically important changes in PROMIS Pain Interference and Physical Function scores during pregnancy and postpartum? METHODS: Between December 2023 and November 2024, we recruited patients scheduled for an obstetrics visit at Penn Medicine clinics in the Philadelphia, PA, USA, area who were between the gestational ages of 6 to 15 weeks, older than 18 years of age, had a BMI less than 45, had no history of connective tissue disorders or trauma to the lower extremities, and could understand and provide written consent. Of 2067 contacted patients, 40 consented and scheduled a laboratory visit; 78% (31 of 40) had complete datasets and were available for analysis. Pregnant participants (mean ± SD age of 35 ± 4 years, mean ± SD BMI of 68.8 ± 11.8 kg) visited the laboratory between 9 and 15 weeks (early pregnancy), 23 and 27 weeks (mid-pregnancy), and 34 and 39 weeks (late pregnancy) of gestation as well as between 9 and 15 weeks postpartum for foot shape assessment and completion of PROMIS scores. We developed a multiplane digital imaging approach designed to capture the top and medial views of the foot simultaneously to allow rapid quantification of foot shape while eliminating exposure to ionizing radiation. We validated this system by longitudinally monitoring foot shape in a control group of 18 nonpregnant participants (mean ± SD age of 28 ± 4 years, mean ± SD BMI of 62.7 ± 6.4 kg) assessed 12 weeks apart. This control group included female patients who had no previous pregnancies, were older than 18 years of age, had a BMI less than 45, had no history of connective tissue disorders or trauma to the lower extremities that resulted in medical intervention, and could provide written consent. We collected PROMIS Pain Interference and Physical Function score assessments during pregnancy and postpartum. Both scores are standardized T-scores and range from 20 to 80, with higher Pain Interference and lower Physical Function scores indicating worse outcomes. Minimum clinically important differences for pain interference and physical function in foot and ankle orthopaedics range between 5.5 and 9.8 T-score points; therefore, we used a conservative threshold of > 10, which represents 1 SD, to identify clinically important changes in pain interference and physical function during pregnancy. RESULTS: We found that foot shape changed from early to late pregnancy, with median (range) increases in left foot width (9.14 cm [8.42 to 11.50] versus 9.30 cm [8.55 to 10.57], median difference +0.21 cm [95% CI 0.06 to 0.25]; p = 0.02), left dorsum height (6.22 cm [5.52 to 7.12] versus 6.33 cm [5.67 to 7.78], median difference +0.17 cm [95% CI 0.01 to 0.46]; p = 0.03), and right dorsum height (6.30 cm [5.51 to 7.58] versus 6.50 cm [5.52 to 7.64], median difference +0.23 cm [95% CI 0.13 to 0.38]; p = 0.008). There were mean ± SD increases in left foot length (24.37 ± 1.24 cm versus 24.66 ± 1.12 cm, mean difference +0.29 cm [95% CI 0.09 to 0.49]; p = 0.03), left medial foot area (83.08 ± 7.12 cm2 versus 87.30 ± 7.15 cm2, mean difference +4.22 cm2 [95% CI 2.19 to 6.25]; p = 0.001), and right medial foot area (84.02 ± 7.71 cm2 versus 88.10 ± 8.53 cm2, mean difference +4.08 cm2 [95% CI 2.21 to 5.94]; p < 0.001). In addition, median (range) left foot width increased from early pregnancy to the postpartum period (9.14 cm [8.42 to 11.50] versus 9.42 cm [8.29 to 10.77], median difference +0.10 cm [95% CI 0.09 to 0.37]; p = 0.01). We found associations between foot shape and patient-reported pain during pregnancy. Pregnant participants with clinically important increases in pain interference from early to late pregnancy had increased right medial foot area during late pregnancy (median [range] 11.37 cm2/shoe size [9.72 to 15.97], median difference +1.02 cm2/shoe size [95% CI 0.42 to 1.73]; p = 0.005) and postpartum (11.26 cm2/shoe size [9.88 to 15.47], median difference +0.91 cm2/shoe size [95% CI 0.04 to 2.57]; p = 0.01) compared to the control group of nonpregnant participants (10.35 cm2/shoe size [8.76 to 11.54]). Pregnant participants with clinically important increases in pain interference from early to late pregnancy also demonstrated an increase in right foot length from early to late pregnancy when compared with nonpregnant participants who had no changes in pain interference (0.49 ± 0.59 cm versus -0.14 ± 0.49 cm, mean difference 0.63 cm [95% CI 0.21 to 1.06]; p = 0.005). Pregnant participants with clinically important declines in physical function had a greater increase in right medial foot area from early to late pregnancy than pregnant participants without a physical function decline (6.62 ± 4.94 cm2 versus 1.98 ± 4.00 cm2, mean difference 4.64 cm2 [95% CI 1.14 to 4.64]; p = 0.01). CONCLUSION: This study identified potential morphological risk factors for musculoskeletal pain and reduced function in pregnant patients. Patient-reported pain and function were predominantly associated with pregnancy-induced lower extremity edema. These findings have potential clinical impact to guide interventions (such as compression socks, massage, or foot elevation) aimed at managing foot changes during pregnancy to reduce musculoskeletal pain and disability.Level of Evidence Level III, prognostic study.
引用
- Meyers M, Russo D, Zawel M, et al. Foot Shape Changes During Pregnancy and Postpartum Are Associated With Patient Pain and Function. Clin Orthop Relat Res. 2026. PMID: 42439597. doi:10.1097/CORR.0000000000004061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。